The largest database of trusted experimental protocols

4 protocols using kmbc2

1

Characterization of Bladder Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Seven BC cell lines (T24, RT112, 253 J‐BV, KMBC2, UMUC3, UMUC6, UMUC13) were grown in RPMI‐1640 (Nissui Pharmaceutical Co., Ltd., Tokyo, Japan) containing 10% fetal bovine serum (BioWhittaker, Walkersville, MD). Cells were cultured in a humidified incubator at 37°C with 5% CO2. T24 and KMBC2 were purchased from the Japanese Collection of Research Bioresources Cell Bank (Osaka, Japan), and the other cell lines were kindly provided by Prof. Peter C. Black (Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada). Authentication of the cell lines was confirmed by short tandem repeat (STR) profiling.
The primer sequences for qRT‐PCR, RNA interference (RNAi), expression vector, proliferation assays, cell migration assays, invasion assays, spheroid colony formation assays, and statistical methods are presented in Data S1.
+ Open protocol
+ Expand
2

Urothelial Carcinoma Cell Line Cultivation and SLFN11 Knockout

Check if the same lab product or an alternative is used in the 5 most similar protocols
Seven urothelial carcinoma cell lines, including T24, UM‐UC13, UM‐UC3, 253JBV, KMBC2, RT112, and UM‐UC6, were used for in vitro experiments. T24 and KMBC2 were purchased from the Japanese Collection of Research Bioresources Cell Bank, and the other cell lines were kindly provided by Professor Peter C. Black (Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia). Cells were cultured in phenol red‐containing minimum essential medium α (Fujifilm Wako Pure Chemical Corporation), supplemented with 10% FBS (BioWhittaker), 50 U/mL penicillin, and 50 µg/mL streptomycin in a humidified incubator with 5% CO2 at 37°C.
The SLFN11 KO cells were established in the T24, UM‐UC13, KMBC2, and RT112 cell lines using CRISPR‐Cas9 methods. Details were described previously.12
+ Open protocol
+ Expand
3

Bladder Cancer Cell Line Cultivation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human bladder cancer-derived cell lines UMUC7, UMUC14, RT112, RT4, VMCUB1, SCaBER, UMUC6, T24 and HT1197 were obtained from DSMZ (Heidelberg, Germany). KMBC2 cells were purchased from JCRB cell bank (Japan). KMBC2 cells were cultured at 37 °C in an atmosphere of 5% CO2 in Ham F12 medium, RT112 and RT4 cells were cultured in RPMI medium and all the other cells were cultured in DMEM medium. All cell media were supplemented with 10% fetal bovine serum (FBS). Cells were routinely tested for mycoplasma contamination.
+ Open protocol
+ Expand
4

Establishing Chemotherapy-Resistant Bladder Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
HT‐1197, HT‐1376, J82, RT4, SW 780, TCCSUP, and UM‐UC‐3 were purchased from ATCC (Manassas, VA, USA). 647‐V, BC‐3C, BFTC‐905, CAL‐29, KU‐19‐19, RT‐112, SW‐1710 and VM‐CUB1 were purchased from DSMZ (Braunschweig, Germany). EJ138, U‐BLC1, UM‐UC‐9 and UM‐UC‐14 were purchased from ECACC (Salisbury, UK). KMBC‐2 and T24 were purchased from JCRB Cell Bank (Osaka, Japan). BOY‐12E, and JMSU‐1 were provided by the RIKEN BRC (Tsukuba, Japan). These cell lines were cultured according to the guidelines from the suppliers.
To generate chemotherapy‐resistant cell lines, UM‐UC‐14 and RT‐112 cell lines were exposed to adriamycin and gemcitabine, respectively, whose concentrations were gradually increased up to 100 and 1000 ng/mL, respectively. Adriamycin‐resistant UM‐UC‐14 and gemcitabine‐resistant RT‐112 cell lines were maintained in the culture medium containing 50 ng/mL adriamycin and 1000 ng/mL gemcitabine, respectively.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!